The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study.
Ouyang M, Sun H, Liu X, Wu H, Deng F, Shen E, Peng G, Wu H, Zhao Y, Xiong H, Liu B, He S, Hu Y, Liu P.
Ouyang M, et al. Among authors: liu x, liu b, liu p.
World J Surg Oncol. 2025 Jan 4;23(1):6. doi: 10.1186/s12957-024-03644-7.
World J Surg Oncol. 2025.
PMID: 39754263
Free PMC article.